Radiotherapy of Uterine Cervical Cancer Using Fletcher-Suit-Delclos Cesium Applicator.
- Author:
Seung Chang SOHN
1
;
Jong Chul YOON
;
Hyun Suk SUH
Author Information
1. Department of Therapeutic Radiology, Inje Nedical College, Seoul Paik Hospital, Korea.
- Publication Type:Original Article
- Keywords:
Uterine cervical cancer;
Fletcher-Suit-Delclos applicator;
Rectal complications
- MeSH:
Cesium*;
Follow-Up Studies;
Humans;
Radiotherapy*;
Survival Rate;
Uterine Cervical Neoplasms*
- From:Journal of the Korean Society for Therapeutic Radiology
1986;4(2):155-164
- CountryRepublic of Korea
- Language:English
-
Abstract:
From Nov. 1983 through Feb. 1986, 35 patients of uterine cervical cancer were treated by external radiation therapy and intracavitary radiation therapy using Fletcher-Sult-Delclos applicator. Age of the patients ranged from 32 to 70 years (median age:53 years). All patients had follow up from 9 to 34 months and median follow up of 20 months. 4 patients were in stage I, 25 were in stage II, 5 were in stage III and I was in stage IV. Overall regression rate was 80% and uncorrected actuarial 2 year survival rate was 88%. The incindence of rectal complications were analyzed. There was no rectal complication in the patients who received less than 7000 rad maximal rectal dose, but 2 out of 17 patients who received more than 7000rad developed moderate degree (grade 2) of rectal complication. In viewing of our results, Fletcher-Suit-Delclos applicator (3M) seemed to be an appropriate instrument for intracavitary radiation therapy in the patients of uterine cervical cancer.
